FUTURE DEFENCE AND SECURITY
Key
capabilities
> Non-invasive cell and tissue imaging for disease diagnostics disease
> Analysis and interpretation of data by using AI
> Development of specialised software
Differentiators
> Sensitive detection of harmful agents aligned with the ‘ human as a sensor ’ paradigm
> Dual-use technology supported by a range of clinical and commercial partnerships
> Nationally recognised technology ( Eureka Award )
Key customers
> Defence sector in the area of human performance
> Specialised clinics in the areas of ophthalmology , neurology , urology and reproduction > Drug manufacturers
Key partnerships > Macquarie University Hospital
Translational Biomedical Diagnostics
Innovation of noninvasive diagnostic tools using hyperspectral autofluorescence imaging technologies
Research Group
Measuring the morphological and biochemical features of tissue is crucial for disease diagnosis and surgical guidance , as it provides clinically significant information related to pathophysiology . Hyperspectral imaging techniques capture both spatial and spectral features of tissue without the need for labelling molecules and offer rich data for improved disease diagnosis and treatment .
The research group is internationally renowned for developing and applying advanced imaging techniques to biomedicine . The group ’ s innovations in non-invasive autofluorescence imaging techniques have led to the development of novel diagnostics methods for eye diseases , cancer , neurodegenerative disorders , and more .
The team is able to analyse image data , create software , unsw . to / arc-leadership
and develop specialised optics hardware . Its projects are supported by the Australian Research Council , Centre of Excellence and Linkage schemes , National Health and Medical Research Council , Juvenile Diabetes Research Foundation , Motor Neuron Disease Research Institute of Australia , and private companies .
• 25